Who Owns Lantern Pharma Stock?
NASDAQ: LTRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 19.32%
- Held by insiders
- 17.36%
- Institutional holders
- 44
- Institutions 19.3%
- Insiders 17.4%
- Public and other 63.3%
Who owns Lantern Pharma stock?
Institutional investors own about 19.3% of Lantern Pharma's shares, spread across 44 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 17.36% of LTRN.
The largest institutional holders are Empery Asset Management, LP (6.59%), CM Management, LLC (3.91%) and Vanguard Capital Management LLC (3.33%). Together, the top 10 institutions control 20.3% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their LTRN positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LTRN
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Empery Asset Management, LP | 842.67K | 6.59% | +100.0% |
| CM Management, LLC | 500.00K | 3.91% | +100.0% |
| Vanguard Capital Management LLC | 425.12K | 3.33% | +28.0% |
| Renaissance Technologies, LLC | 291.04K | 2.28% | +150.9% |
| Bios Capital Management, LP | 249.40K | 1.95% | -71.2% |
| Geode Capital Management, LLC | 102.82K | 0.80% | -7.9% |
| Vanguard Fiduciary Trust Co | 49.95K | 0.39% | +0.7% |
| Citadel Advisors Llc | 47.90K | 0.37% | +100.0% |
| Westside Investment Management, Inc. | 47.85K | 0.37% | -4.4% |
| Quadrature Capital Ltd | 39.59K | 0.31% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LTRN
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 338.38K | 2.65% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 81.10K | 0.63% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 45.01K | 0.35% |
| Listed Funds Trust-Horizon Kinetics Medical ETF | 25.16K | 0.20% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 17.48K | 0.14% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 15.27K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 6.84K | 0.05% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 4.83K | 0.04% |
| Dimensional ETF Trust-Dimensional US Sustainability Core 1 ETF | 1.92K | 0.02% |
| Dimensional ETF Trust-Dimensional US Core Equity 2 ETF | 643 | 0.01% |
Frequently asked questions
Who is the largest shareholder of Lantern Pharma?
Empery Asset Management, LP is the largest institutional shareholder of LTRN, owning 6.59% of shares outstanding (842.67K shares) as of its latest 13F filing.
What percentage of Lantern Pharma is owned by institutions?
Institutions own about 19.3% of LTRN shares and 23.4% of the public float.
How much of Lantern Pharma do insiders own?
Insiders, such as officers and directors, own about 17.36% of LTRN shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.